Anti-CD228/MELTF Polyclonal Antibody

Anti-CD228/MELTF Polyclonal Antibody

The Anti-CD228/MELTF Polyclonal Antibody is a highly specific and sensitive antibody that targets CD228, also known as MELTF (melanoma-associated antigen), a cell surface glycoprotein involved in cell adhesion and migration. This antibody is an essential tool for researchers in the field of biotechnology, specifically in the study of cancer and immune system disorders.

Biological Function:
CD228 is a transmembrane protein that plays a crucial role in cell adhesion and migration, making it a potential target for cancer therapy. It is highly expressed in melanoma cells and has been shown to be involved in the metastasis of melanoma. The Anti-CD228/MELTF Polyclonal Antibody binds to CD228 and inhibits its function, thus preventing the spread of cancer cells.

Main Applications:
The Anti-CD228/MELTF Polyclonal Antibody is commonly used in research studies to investigate the role of CD228 in cancer development and progression. It can also be used for diagnostic purposes, as CD228 is a potential biomarker for melanoma. Furthermore, this antibody can be used in the development of novel cancer therapies targeting CD228.

Experimental Use Cases:
The Anti-CD228/MELTF Polyclonal Antibody has been successfully used in various experimental settings, including flow cytometry, immunohistochemistry, and western blotting. It has been shown to specifically bind to CD228 in various cell types, including melanoma cells, making it a reliable tool for researchers.

This antibody is specifically designed to target CD228, making it a valuable tool for researchers studying cancer and immune system disorders. Its high specificity and sensitivity make it an ideal choice for experiments such as flow cytometry, immunohistochemistry, and western blotting.

Structure:
– Introduction: Briefly introduce the product and its purpose.
– Biological Function: Explain the role of CD228 in cell adhesion and migration.
– Main Applications: Highlight the potential uses of the Anti-CD228/MELTF Polyclonal Antibody in cancer research and diagnosis.
– Experimental Use Cases: Describe the successful use of this antibody in various experimental settings.
– Emphasize the specificity and sensitivity of the antibody for CD228.
– Conclusion: Summarize the key points and highlight the relevance of this antibody for biotech research.

In conclusion, the Anti-CD228/MELTF Polyclonal Antibody is a powerful tool for researchers in the biotech industry. Its specificity for CD228 and its ability to inhibit its function make it an essential component in the study of cancer and immune system disorders. With its proven success in various experimental settings, this antibody is a reliable choice for researchers looking to advance their understanding of CD228 and its role in disease.